Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Chronic Care Demo Projects Likely To Meet 5% Savings Goal, Rep. Johnson Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Based on "huge response" to RFP "bidders' conference," Rep. Johnson says that level of savings is achievable. CMS expects to begin implementing the service agreements in December.

You may also be interested in...



AHRQ Rx Comparisons Should Focus On Existing Literature, Not Clinical Trials, McClellan Says

Clinical trials take too much time and money, CMS Administrator McClellan says. Programs mandated under Medicare Rx law, such as the chronic care improvement pilot and the Part B replacement drug demo, will provide clinical data to evaluate comparative effectiveness, he says.

AHRQ Rx Comparisons Should Focus On Existing Literature, Not Clinical Trials, McClellan Says

Clinical trials take too much time and money, CMS Administrator McClellan says. Programs mandated under Medicare Rx law, such as the chronic care improvement pilot and the Part B replacement drug demo, will provide clinical data to evaluate comparative effectiveness, he says.

Medicare Disease Management Fees Contingent On Outcomes, Savings

Contractors must save Medicare at least 5% in the chronic care pilot programs or forfeit their fees.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059374

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel